Why invest in XPhyto

We’re leading ground-breaking work in pharmaceuticals

There is a vast portion of the pharmaceutical landscape just waiting to be explored for the next big advancement. That’s where we live. From applying psychedelics to major neurological diseases to developing rapid testing to support pandemic management, our work is all about innovation to impact.

Latest Press Releases

Stock Information

Following a successful business year in 2020, XPhyto is well positioned to execute on important core milestones in all focus areas, including the commercialization of infectious disease diagnostics; the clinical validation of transdermal and sublingual drug formulations; and continued development of psychedelic medicine.

Corporate Directory

Legal Council

McMillan LLP

Royal Centre, Suite 1500
1055 West Georgia Street,
PO Box 11117
Vancouver, BC V6E 4N7
Canada

Auditor

Davidson & Company

609 Granville Street, Suite 1200
P.O. Box 10372, Pacific Centre
Vancouver, BC V7Y 1G6
Canada

Transfer Agent

Computershare Trust
Company of Canada

510 Burrard Street
Vancouver, BC V6C 3B9
Canada

Request Investor Information

Get in touch to receive our investors package.

If you have specific questions, leave a note of us in the form below.
We’ll get back to you right away.

XPhyto Investment Vancouver City Skyline at Night
Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.